Lv41
430 积分 2021-06-08 加入
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
1小时前
待确认
Ovarian Clear Cell Carcinoma: An Endometriosis-Associated Cancer with Therapeutic Challenges
1个月前
已完结
Ovarian clear cell carcinoma as a stress-responsive cancer: Influence of the microenvironment on the carcinogenesis and cancer phenotype
1个月前
已完结
Simultaneously Detected Endometrial and Ovarian Carcinomas— A Prospective Clinicopathologic Study of 74 Cases: A Gynecologic Oncology Group Study
2个月前
已完结
A Proteogenomic View of Synchronous Endometrioid Endometrial and Ovarian Cancer
2个月前
已完结
Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
3个月前
已完结
A randomized phase 3 trial of intraperitoneal versus intravenous carboplatin with dose-dense weekly paclitaxel in patients with ovarian, fallopian tube, or primary peritoneal carcinoma (a GOTIC-001/JGOG-3019/GCIG, iPocc Trial) (LBA 3)
3个月前
已关闭
皖公网安备34019202002308
